Thermo Fisher Scientific, Medidata Acorn AI: site selection and patient enrollment collaboration
Thermo Fisher Scientific is joining forces with Medidata Acorn AI, a Dassault Systèmes company, on site selection and patient enrollment solutions. The PPD clinical research business of Thermo Fisher has worked with Medidata to develop PPD TrueCast, which combines patient recruitment and site performance data with predictive models and advanced analytics.
“The clinical trial industry continues to demand new tools in big data and predictive analytics to improve trial planning and execution and accelerate clinical trials,” said David Johnston, senior vice president and president of clinical research with Thermo Fisher Scientific. “As a result of the vast site-level data amassed by PPD and Medidata, customers now have even greater visibility into how a trial is performing for any study our clinical research business is helping them run.”
